Today, AlphaTON Capital announces our intention to launch a decentralized, AI-native biotech platform focusing on rare cancers.

Rare cancers are underfunded, under-researched, and overlooked — yet millions of families live this reality every day.

By combining AI, decentralized infrastructure, and global collaboration, our goal is simple: help accelerate discovery, access, and hope where it’s needed most. To save lives 🙏

Learn more below 👇 👇

NASDAQ: $ATON 💎 🚀 🎯